Women’s Mid-Life Night Sweats and 2-Year Bone Mineral Density Changes: A Prospective, Observational Population-Based Investigation from the Canadian Multicentre Osteoporosis Study (CaMos)

Women’s hot flushes and night sweats, collectively called vasomotor symptoms (VMS), are maximal (79%) in late perimenopause. The evidence describing whether VMS are associated with loss of areal bone mineral density (BMD) is mixed. We examined baseline and 2-year data for 1570 randomly selected wome...

Full description

Bibliographic Details
Main Authors: Evelyn M. M. Wong, George Tomlinson, Marsha M. Pinto, Claudie Berger, Angela M. Cheung, Jerilynn C. Prior
Format: Article
Language:English
Published: MDPI AG 2018-05-01
Series:International Journal of Environmental Research and Public Health
Subjects:
Online Access:http://www.mdpi.com/1660-4601/15/6/1079
id doaj-aaea11c22520432aa9d2374c6052e660
record_format Article
spelling doaj-aaea11c22520432aa9d2374c6052e6602020-11-24T23:16:16ZengMDPI AGInternational Journal of Environmental Research and Public Health1660-46012018-05-01156107910.3390/ijerph15061079ijerph15061079Women’s Mid-Life Night Sweats and 2-Year Bone Mineral Density Changes: A Prospective, Observational Population-Based Investigation from the Canadian Multicentre Osteoporosis Study (CaMos)Evelyn M. M. Wong0George Tomlinson1Marsha M. Pinto2Claudie Berger3Angela M. Cheung4Jerilynn C. Prior5Division of Endocrinology and Metabolism, Department of Medicine, University of British Columbia, Vancouver, BC V5Z 1M9, CanadaInstitute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON M5G 2C4, CanadaOsteoporosis Program, University Health Network, Toronto, ON M5G 2C4, CanadaCanadian Multicentre Osteoporosis Study Data Management Group, McGill University, Montreal, ON H4A 3S5, CanadaDivision of Endocrinology and Metabolism, Department of Medicine, University Health Network and Sinai Health System, University of Toronto, Toronto, ON M5G 2C4, CanadaDivision of Endocrinology and Metabolism, Department of Medicine, University of British Columbia, Vancouver, BC V5Z 1M9, CanadaWomen’s hot flushes and night sweats, collectively called vasomotor symptoms (VMS), are maximal (79%) in late perimenopause. The evidence describing whether VMS are associated with loss of areal bone mineral density (BMD) is mixed. We examined baseline and 2-year data for 1570 randomly selected women aged 43–63 in the Canadian Multicentre Osteoporosis Study (CaMos), a prospective Canada-wide study; we used linear regression to assess the relationship of night sweats (VMSn) with BMD and its changes. Clinically important VMSn occurred for 12.2%. Women with VMSn were slightly younger (54.5 vs. 55.3 years, p = 0.02) and less likely to use sex steroid therapies (39.8% vs. 51.4%, p < 0.05). BMD at the lumbar spine (L1-4), femoral neck (FN) and total hip (TH) were similar between those with/without VMSn. In adjusted models, we did not find a significant association between VMSn and 2-year change in L1-4, FN and TH BMD. Age, reproductive status, weight, sex steroid therapy and smoking status were associated with 2-year change in BMD. Incident fractures over 2 years also did not differ by VMSn. Our analyses were restricted to VMSn and may not truly capture the relationship between VMS and BMD. Additional research involving VMS, bone loss and fracture incidence is needed.http://www.mdpi.com/1660-4601/15/6/1079vasomotor symptomshot flashesnight sweatsmenopausewomenperimenopauseosteoporosisspinal fractureship fracturesbone density
collection DOAJ
language English
format Article
sources DOAJ
author Evelyn M. M. Wong
George Tomlinson
Marsha M. Pinto
Claudie Berger
Angela M. Cheung
Jerilynn C. Prior
spellingShingle Evelyn M. M. Wong
George Tomlinson
Marsha M. Pinto
Claudie Berger
Angela M. Cheung
Jerilynn C. Prior
Women’s Mid-Life Night Sweats and 2-Year Bone Mineral Density Changes: A Prospective, Observational Population-Based Investigation from the Canadian Multicentre Osteoporosis Study (CaMos)
International Journal of Environmental Research and Public Health
vasomotor symptoms
hot flashes
night sweats
menopause
women
perimenopause
osteoporosis
spinal fractures
hip fractures
bone density
author_facet Evelyn M. M. Wong
George Tomlinson
Marsha M. Pinto
Claudie Berger
Angela M. Cheung
Jerilynn C. Prior
author_sort Evelyn M. M. Wong
title Women’s Mid-Life Night Sweats and 2-Year Bone Mineral Density Changes: A Prospective, Observational Population-Based Investigation from the Canadian Multicentre Osteoporosis Study (CaMos)
title_short Women’s Mid-Life Night Sweats and 2-Year Bone Mineral Density Changes: A Prospective, Observational Population-Based Investigation from the Canadian Multicentre Osteoporosis Study (CaMos)
title_full Women’s Mid-Life Night Sweats and 2-Year Bone Mineral Density Changes: A Prospective, Observational Population-Based Investigation from the Canadian Multicentre Osteoporosis Study (CaMos)
title_fullStr Women’s Mid-Life Night Sweats and 2-Year Bone Mineral Density Changes: A Prospective, Observational Population-Based Investigation from the Canadian Multicentre Osteoporosis Study (CaMos)
title_full_unstemmed Women’s Mid-Life Night Sweats and 2-Year Bone Mineral Density Changes: A Prospective, Observational Population-Based Investigation from the Canadian Multicentre Osteoporosis Study (CaMos)
title_sort women’s mid-life night sweats and 2-year bone mineral density changes: a prospective, observational population-based investigation from the canadian multicentre osteoporosis study (camos)
publisher MDPI AG
series International Journal of Environmental Research and Public Health
issn 1660-4601
publishDate 2018-05-01
description Women’s hot flushes and night sweats, collectively called vasomotor symptoms (VMS), are maximal (79%) in late perimenopause. The evidence describing whether VMS are associated with loss of areal bone mineral density (BMD) is mixed. We examined baseline and 2-year data for 1570 randomly selected women aged 43–63 in the Canadian Multicentre Osteoporosis Study (CaMos), a prospective Canada-wide study; we used linear regression to assess the relationship of night sweats (VMSn) with BMD and its changes. Clinically important VMSn occurred for 12.2%. Women with VMSn were slightly younger (54.5 vs. 55.3 years, p = 0.02) and less likely to use sex steroid therapies (39.8% vs. 51.4%, p < 0.05). BMD at the lumbar spine (L1-4), femoral neck (FN) and total hip (TH) were similar between those with/without VMSn. In adjusted models, we did not find a significant association between VMSn and 2-year change in L1-4, FN and TH BMD. Age, reproductive status, weight, sex steroid therapy and smoking status were associated with 2-year change in BMD. Incident fractures over 2 years also did not differ by VMSn. Our analyses were restricted to VMSn and may not truly capture the relationship between VMS and BMD. Additional research involving VMS, bone loss and fracture incidence is needed.
topic vasomotor symptoms
hot flashes
night sweats
menopause
women
perimenopause
osteoporosis
spinal fractures
hip fractures
bone density
url http://www.mdpi.com/1660-4601/15/6/1079
work_keys_str_mv AT evelynmmwong womensmidlifenightsweatsand2yearbonemineraldensitychangesaprospectiveobservationalpopulationbasedinvestigationfromthecanadianmulticentreosteoporosisstudycamos
AT georgetomlinson womensmidlifenightsweatsand2yearbonemineraldensitychangesaprospectiveobservationalpopulationbasedinvestigationfromthecanadianmulticentreosteoporosisstudycamos
AT marshampinto womensmidlifenightsweatsand2yearbonemineraldensitychangesaprospectiveobservationalpopulationbasedinvestigationfromthecanadianmulticentreosteoporosisstudycamos
AT claudieberger womensmidlifenightsweatsand2yearbonemineraldensitychangesaprospectiveobservationalpopulationbasedinvestigationfromthecanadianmulticentreosteoporosisstudycamos
AT angelamcheung womensmidlifenightsweatsand2yearbonemineraldensitychangesaprospectiveobservationalpopulationbasedinvestigationfromthecanadianmulticentreosteoporosisstudycamos
AT jerilynncprior womensmidlifenightsweatsand2yearbonemineraldensitychangesaprospectiveobservationalpopulationbasedinvestigationfromthecanadianmulticentreosteoporosisstudycamos
_version_ 1725587912113782784